{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:43:05Z","timestamp":1791405785228,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81974255"],"award-info":[{"award-number":["81974255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10875-020-00749-y","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T12:02:37Z","timestamp":1579262557000},"page":"378-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["E1021K Homozygous Mutation in PIK3CD Leads to Activated PI3K-Delta Syndrome 1"],"prefix":"10.1007","volume":"40","author":[{"given":"Yanping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"749_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo I, Vadas O, Gar\u00e7on F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342:866\u201371.","journal-title":"Science."},{"key":"749_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri.2016.93","volume":"16","author":"CL Lucas","year":"2016","unstructured":"Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K. PI3K\u03b4 and primary immunodeficiencies. Nat Rev Immunol. 2016;16:702\u201314.","journal-title":"Nat Rev Immunol"},{"key":"749_CR3","first-page":"1","volume":"3","author":"JM Han","year":"2012","unstructured":"Han JM, Patterson SJ, Levings MK. The role of the PI3K signaling pathway in CD4+ T cell differentiation and function. Front Immunol. 2012;3:1\u201312.","journal-title":"Front Immunol"},{"key":"749_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study. J Allergy Clin Immunol. 2017;139:597\u2013606.e4.","journal-title":"J Allergy Clin Immunol"},{"key":"749_CR5","doi-asserted-by":"crossref","unstructured":"Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, et al. Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): a systematic review. Clin Rev Allergy Immunol. 2019.","DOI":"10.1007\/s12016-019-08738-9"},{"key":"749_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s10875-018-0568-x","volume":"38","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang W, Liu L, Hou J, Ying W, Hui X, et al. Report of a Chinese cohort with activated Phosphoinositide 3-kinase \u03b4 syndrome. J Clin Immunol. 2018;38:854\u201363.","journal-title":"J Clin Immunol"},{"key":"749_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00369","volume":"9","author":"D Michalovich","year":"2018","unstructured":"Michalovich D, Nejentsev S. Activated PI3 kinase delta syndrome: from genetics to therapy. Front Immunol. 2018;9:1\u20136.","journal-title":"Front Immunol"},{"key":"749_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clim.2019.01.003","volume":"200","author":"V Lougaris","year":"2019","unstructured":"Lougaris V, Baronio M, Moratto D, Tampella G, Gazzurelli L, Facchetti M, et al. A novel monoallelic gain of function mutation in p110\u03b4 causing atypical activated phosphoinositide 3-kinase \u03b4 syndrome (APDS-1). Clin Immunol. 2019;200:31\u20134.","journal-title":"Clin Immunol"},{"key":"749_CR9","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.3324\/haematol.2017.167601","volume":"102","author":"L Heurtier","year":"2017","unstructured":"Heurtier L, Lamrini H, Chentout L, Deau MC, Bouafia A, Rosain J, et al. Mutations in the adaptor-binding domain and associated linker region of p110\u03b4 cause activated PI3K-\u03b4. syndrome 1 (APDS1). Haematologica. 2017;102:e278\u201381.","journal-title":"Haematologica."},{"key":"749_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clim.2017.05.020","volume":"181","author":"W Rae","year":"2017","unstructured":"Rae W, Gao Y, Ward D, Mattocks CJ, Eren E, Williams AP. A novel germline gain-of-function variant in PIK3CD. Clin Immunol. 2017;181:29\u201331.","journal-title":"Clin Immunol"},{"key":"749_CR11","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jaci.2017.03.026","volume":"140","author":"AJ Takeda","year":"2017","unstructured":"Takeda AJ, Zhang Y, Dornan GL, Siempelkamp BD, Jenkins ML, Matthews HF, et al. Novel PIK3CD mutations affecting N-terminal residues of p110\u03b4 cause activated PI3K\u03b4 syndrome (APDS) in humans. J Allergy Clin Immunol. 2017;140:1152\u20131156.e10.","journal-title":"J Allergy Clin Immunol"},{"key":"749_CR12","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.1617244114","volume":"114","author":"GL Dornan","year":"2017","unstructured":"Dornan GL, Siempelkamp BD, Jenkins ML, Vadas O, Lucas CL, Burke JE. Conformational disruption of PI3K\u03b4 regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc Natl Acad Sci U S A. 2017;114:1982\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"749_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jaci.2018.04.022","volume":"142","author":"Y Ding","year":"2018","unstructured":"Ding Y, Zhou L, Xia Y, Wang W, Wang Y, Li L, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142:970\u2013973.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"749_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ajhg.2016.08.007","volume":"99","author":"T Harel","year":"2016","unstructured":"Harel T, Yoon WH, Garone C, Gu S, Coban-Akdemir Z, Eldomery MK, et al. Recurrent De novo and Biallelic variation of ATAD3A, encoding a mitochondrial membrane protein, results in distinct neurological syndromes. Am J Hum Genet. 2016;99:831\u201345.","journal-title":"Am J Hum Genet"},{"key":"749_CR15","first-page":"698","volume":"54","author":"H Liu","year":"2016","unstructured":"Liu H, Tang XL, Liu JR, Li HM, Zhao SY. Clinical and genetic analysis for activated PI3K-\u03b4 syndrome by PIK3CD gene mutation. Chinese J Pediatr. 2016;54:698\u2013702.","journal-title":"Chinese J Pediatr"},{"key":"749_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02397","volume":"9","author":"P Soler-Palac\u00edn","year":"2018","unstructured":"Soler-Palac\u00edn P, Garcia-Prat M, Mart\u00edn-Nalda A, Franco-Jarava C, Rivi\u00e8re JG, Plaja A, et al. LRBA deficiency in a patient with a novel homozygous mutation due to chromosome 4 segmental uniparental isodisomy. Front Immunol. 2018;9:1\u20136.","journal-title":"Front Immunol"},{"key":"749_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ajmg.c.30270","volume":"154","author":"K Yamazawa","year":"2010","unstructured":"Yamazawa K, Ogata T, Ferguson-Smith AC. Uniparental disomy and human disease: an overview. Am J Med Genet Part C Semin Med Genet. 2010;154:329\u201334.","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"749_CR18","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jaip.2017.01.018","volume":"5","author":"M Bravo Garc\u00eda-Morato","year":"2017","unstructured":"Bravo Garc\u00eda-Morato M, Nevado J, Gonz\u00e1lez-Granado LI, Sastre Urgelles A, Rodr\u00edguez Pena R, Ferreira CA. Chronic granulomatous disease caused by maternal uniparental isodisomy of chromosome 16. J Allergy Clin Immunol Pract. 2017;5:1146\u20138.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"749_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaci.2018.09.009","volume":"143","author":"A Mensa-Vilar\u00f3","year":"2019","unstructured":"Mensa-Vilar\u00f3 A, Bravo Garc\u00eda-Morato M, de la Calle-Martin O, Franco-Jarava C, Mart\u00ednez-Saavedra MT, Gonz\u00e1lez-Granado LI, et al. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases. J Allergy Clin Immunol. 2019;143:359\u201368.","journal-title":"J Allergy Clin Immunol"},{"key":"749_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ajmg.c.31421","volume":"166","author":"NB Spinner","year":"2014","unstructured":"Spinner NB, Conlin LK. Mosaicism and clinical genetics. Am J Med Genet Part C Semin Med Genet. 2014;166:397\u2013405.","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"749_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1172\/JCI117740","volume":"95","author":"JM Puck","year":"1995","unstructured":"Puck JM, Pepper AE, Bedard PM, Laframboise R. Female germ line mosaicism as the origin of a unique IL-2 receptor \u03b3-chain mutation causing X-linked severe combined immunodeficiency. J Clin Invest. 1995;95:895\u20139.","journal-title":"J Clin Invest"},{"key":"749_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ajmg.a.60693","volume":"179","author":"X Pang","year":"2019","unstructured":"Pang X, Zheng X, Kong X, Chai Y, Wang Y, Qian H, et al. A homozygous MITF mutation leads to familial Waardenburg syndrome type 4. Am J Med Genet Part A. 2019;179:243\u20138.","journal-title":"Am J Med Genet Part A"},{"key":"749_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jns.2016.12.051","volume":"373","author":"K Soga","year":"2017","unstructured":"Soga K, Ishikawa K, Furuya T, Iida T, Yamada T, Ando N, et al. Gene dosage effect in spinocerebellar ataxia type 6 homozygotes: a clinical and neuropathological study. J Neurol Sci. 2017;373:321\u20138.","journal-title":"J Neurol Sci"},{"key":"749_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nmd.2006.01.006","volume":"16","author":"GM Fabrizi","year":"2006","unstructured":"Fabrizi GM, Pellegrini M, Angiari C, Cavallaro T, Morini A, Taioli F, et al. Gene dosage sensitivity of a novel mutation in the intracellular domain of P0 associated with Charcot-Marie-tooth disease type 1B. Neuromuscul Disord. 2006;16:183\u20137.","journal-title":"Neuromuscul Disord"},{"key":"749_CR25","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/ndt\/gfx066","volume":"32","author":"N Edwards","year":"2017","unstructured":"Edwards N, Olinger E, Adam J, Kelly M, Schiano G, Ramsbottom SA, et al. A novel homozygous UMOD mutation reveals gene dosage effects on uromodulin processing and urinary excretion. Nephrol Dial Transplant. 2017;32:1994\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"749_CR26","doi-asserted-by":"publisher","first-page":"8380","DOI":"10.1073\/pnas.1821093116","volume":"116","author":"RR Madsen","year":"2019","unstructured":"Madsen RR, Knox RG, Pearce W, Lopez S, Mahler-Araujo B, McGranahan N, et al. Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner. Proc Natl Acad Sci U S A. 2019;116:8380\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"749_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15:88\u201397.","journal-title":"Nat Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00749-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-020-00749-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00749-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:11:08Z","timestamp":1610755868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-020-00749-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00749-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from all the participants. This study was conducted in accordance with the tenets of the Declaration of Helsinki and was approved by the ethics committee of Chongqing Medical University. All animal work was reviewed and approved by the Institutional Animal Care and Usage Committee of the Children\u2019s Hospital of Chongqing Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}